The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...
In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...
In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III global research program — CREDO (Clinical RhEumatoid Arthritis Development...
Haikou city, the administrative center of Hainan, announced the opening of the island's first modern pharmaceutical equipment maintenance facility, TASS reports with a reference...
Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...
PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS).
According to the results of 9...